Phase I study of combination chemotherapy with amrubicin and paclitaxel in relapsed small cell lung cancer

18206 Background: Amrubicin (AMR) and paclitaxel (PTX) are promising agents for advanced non-small cell and small cell lung cancer (SC). However, the combination of these drugs for relapsed SC has ...